FERRARA PIETRO

Zamagni, G., Carreras, G., Armocida, B., Gakidou, E., Ashbaugh, C., Alicandro, G., et al. (2026). National and subnational burden of disease attributable to risk factors in Italy, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023. THE LANCET PUBLIC HEALTH, 11(5), 293-305 [10.1016/S2468-2667(26)00048-4]. Detail

Geraci, G., Paternò, V., Vitello, A., Maida, M., Bonomo, F., Sanfilippo, S., et al. (2026). Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction–associated steatotic liver disease. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION [10.1007/s40618-026-02908-1]. Detail

Geraci, G., Ferrara, P., Piticchio, T., Le Moli, R., Paternò, V., Calabrese, V., et al. (2026). Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiography. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 36(4) [10.1016/j.numecd.2025.104518]. Detail

Sirota, S., Bender, R., Dominguez, R., Vongpradith, A., Movo, A., Swetschinski, L., et al. (2026). Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. LANCET NEUROLOGY, 25(5), 451-468 [10.1016/S1474-4422(26)00101-8]. Detail

Antonazzo, I., Fornari, C., Buongarzone, G., Ferrara, P., Crotti, G., Zucchi, A., et al. (2026). Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study. EPILEPSIA, 67(2), 686-695 [10.1111/epi.18706]. Detail